{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,20]],"date-time":"2026-08-20T15:41:36Z","timestamp":1787240496297,"version":"build-2736575974"},"reference-count":47,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2022,6,1]],"date-time":"2022-06-01T00:00:00Z","timestamp":1654041600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,6,1]],"date-time":"2022-06-01T00:00:00Z","timestamp":1654041600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,4,29]],"date-time":"2022-04-29T00:00:00Z","timestamp":1651190400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","thegreenjournal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Radiotherapy and Oncology"],"published-print":{"date-parts":[[2022,6]]},"DOI":"10.1016\/j.radonc.2022.04.008","type":"journal-article","created":{"date-parts":[[2022,4,15]],"date-time":"2022-04-15T19:04:13Z","timestamp":1650049453000},"page":"77-83","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":9,"special_numbering":"C","title":["Proton therapy for the treatment of inflammatory breast cancer"],"prefix":"10.1016","volume":"171","author":[{"given":"Sayeh","family":"Fattahi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Trey C.","family":"Mullikin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Khaled A.","family":"Aziz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Arslan","family":"Afzal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Na L.","family":"Smith","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Leah N.","family":"Francis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"W. Scott","family":"Harmsen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David M.","family":"Routman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicholas B.","family":"Remmes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Safia K.","family":"Ahmed","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dean A.","family":"Shumway","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sean S.","family":"Park","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert W.","family":"Mutter","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kimberly S.","family":"Corbin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.radonc.2022.04.008_b0005","first-page":"321","article-title":"Population-based statistics for women diagnosed with inflammatory breast cancer (United States)","volume":"15","author":"Wingo","year":"2004","journal-title":"Cancer Causes Control"},{"key":"10.1016\/j.radonc.2022.04.008_b0010","doi-asserted-by":"crossref","first-page":"966","DOI":"10.1093\/jnci\/dji172","article-title":"Trends in inflammatory breast carcinoma incidence and survival: the surveillance, epidemiology, and end results program at the National Cancer Institute","volume":"97","author":"Hance","year":"2005","journal-title":"J Natl Cancer Inst"},{"key":"10.1016\/j.radonc.2022.04.008_b0015","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1053\/j.seminoncol.2007.11.018","article-title":"The epidemiology of inflammatory breast cancer","volume":"35","author":"Levine","year":"2008","journal-title":"Semin Oncol"},{"key":"10.1016\/j.radonc.2022.04.008_b0020","doi-asserted-by":"crossref","first-page":"9","DOI":"10.3233\/BD-2006-22103","article-title":"Epidemiology of inflammatory breast cancer (IBC)","volume":"22","author":"Anderson","year":"2005","journal-title":"Breast Dis"},{"key":"10.1016\/j.radonc.2022.04.008_b0025","doi-asserted-by":"crossref","first-page":"920","DOI":"10.1002\/cncr.20083","article-title":"Inflammatory breast carcinoma: outcomes with trimodality therapy for nonmetastatic disease","volume":"100","author":"Liauw","year":"2004","journal-title":"Cancer"},{"key":"10.1016\/j.radonc.2022.04.008_b0030","doi-asserted-by":"crossref","first-page":"1200","DOI":"10.1016\/S0360-3016(02)04201-3","article-title":"Ten-year outcome after combined modality therapy for inflammatory breast cancer","volume":"55","author":"Harris","year":"2003","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.radonc.2022.04.008_b0035","doi-asserted-by":"crossref","first-page":"358","DOI":"10.3816\/CBC.2004.n.042","article-title":"Long-term results of combined-modality therapy for inflammatory breast carcinoma","volume":"5","author":"Baldini","year":"2004","journal-title":"Clin Breast Cancer"},{"key":"10.1016\/j.radonc.2022.04.008_b0040","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1007\/s002800050664","article-title":"Combined-modality treatment of inflammatory breast carcinoma: twenty years of experience at M. D. Anderson Cancer Center","volume":"40","author":"Ueno","year":"1997","journal-title":"Cancer Chemother Pharmacol"},{"key":"10.1016\/j.radonc.2022.04.008_b0045","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1093\/annonc\/mdq345","article-title":"International expert panel on inflammatory breast cancer: consensus statement for standardized diagnosis and treatment","volume":"22","author":"Dawood","year":"2011","journal-title":"Ann Oncol"},{"key":"10.1016\/j.radonc.2022.04.008_b0050","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1634\/theoncologist.8-2-141","article-title":"Update on the management of inflammatory breast cancer","volume":"8","author":"Cristofanilli","year":"2003","journal-title":"Oncologist"},{"key":"10.1016\/j.radonc.2022.04.008_b0055","doi-asserted-by":"crossref","first-page":"997","DOI":"10.1016\/j.ijrobp.2014.01.054","article-title":"Once-daily radiation therapy for inflammatory breast cancer","volume":"89","author":"Brown","year":"2014","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.radonc.2022.04.008_b0060","doi-asserted-by":"crossref","first-page":"1191","DOI":"10.1016\/S0360-3016(00)00561-7","article-title":"Locoregional irradiation for inflammatory breast cancer: effectiveness of dose escalation in decreasing recurrence","volume":"47","author":"Liao","year":"2000","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.radonc.2022.04.008_b0065","doi-asserted-by":"crossref","first-page":"474","DOI":"10.1016\/j.ijrobp.2008.01.039","article-title":"Locoregional treatment outcomes after multimodality management of inflammatory breast cancer","volume":"72","author":"Bristol","year":"2008","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.radonc.2022.04.008_b0070","doi-asserted-by":"crossref","first-page":"987","DOI":"10.1056\/NEJMoa1209825","article-title":"Risk of ischemic heart disease in women after radiotherapy for breast cancer","volume":"368","author":"Darby","year":"2013","journal-title":"N Engl J Med"},{"key":"10.1016\/j.radonc.2022.04.008_b0075","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1056\/NEJMoa1415340","article-title":"Regional nodal irradiation in early-stage breast cancer","volume":"373","author":"Whelan","year":"2015","journal-title":"N Engl J Med"},{"key":"10.1016\/j.radonc.2022.04.008_b0080","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1056\/NEJMoa1415369","article-title":"Internal mammary and medial supraclavicular irradiation in breast cancer","volume":"373","author":"Poortmans","year":"2015","journal-title":"N Engl J Med"},{"key":"10.1016\/j.radonc.2022.04.008_b0085","doi-asserted-by":"crossref","first-page":"E57","DOI":"10.1016\/j.ijrobp.2019.06.2392","article-title":"Estimated risk for a second malignancy after proton and photon radiation therapy for breast cancer","volume":"105","author":"Paganetti","year":"2019","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.radonc.2022.04.008_b0090","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1186\/1748-717X-8-71","article-title":"Proton radiotherapy for chest wall and regional lymphatic radiation; dose comparisons and treatment delivery","volume":"8","author":"MacDonald","year":"2013","journal-title":"Radiat Oncol"},{"key":"10.1016\/j.radonc.2022.04.008_b0095","doi-asserted-by":"crossref","first-page":"e243","DOI":"10.1016\/j.prro.2016.12.002","article-title":"Initial clinical experience of postmastectomy intensity modulated proton therapy in patients with breast expanders with metallic ports","volume":"7","author":"Mutter","year":"2017","journal-title":"Pract Radiat Oncol"},{"key":"10.1016\/j.radonc.2022.04.008_b0100","doi-asserted-by":"crossref","first-page":"1084","DOI":"10.1016\/j.ijrobp.2019.04.015","article-title":"Quantification of acute skin toxicities in patients with breast cancer undergoing adjuvant proton versus photon radiation therapy: a single institutional experience","volume":"104","author":"DeCesaris","year":"2019","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.radonc.2022.04.008_b0105","doi-asserted-by":"crossref","first-page":"2778","DOI":"10.1200\/JCO.18.02366","article-title":"Phase II study of proton beam radiation therapy for patients with breast cancer requiring regional nodal irradiation","volume":"37","author":"Jimenez","year":"2019","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.radonc.2022.04.008_b0110","doi-asserted-by":"crossref","first-page":"284","DOI":"10.1016\/j.ijrobp.2015.01.005","article-title":"Early toxicity in patients treated with postoperative proton therapy for locally advanced breast cancer","volume":"92","author":"Cuaron","year":"2015","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.radonc.2022.04.008_b0115","doi-asserted-by":"crossref","first-page":"250","DOI":"10.1016\/j.radonc.2018.10.002","article-title":"Early outcomes of breast cancer patients treated with post-mastectomy uniform scanning proton therapy","volume":"132","author":"Luo","year":"2019","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.radonc.2022.04.008_b0120","doi-asserted-by":"crossref","first-page":"294","DOI":"10.1016\/j.radonc.2017.04.007","article-title":"Proton beam radiotherapy as part of comprehensive regional nodal irradiation for locally advanced breast cancer","volume":"123","author":"Verma","year":"2017","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.radonc.2022.04.008_b0125","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1016\/j.radonc.2019.05.022","article-title":"Post-mastectomy intensity modulated proton therapy after immediate breast reconstruction: Initial report of reconstruction outcomes and predictors of complications","volume":"140","author":"Smith","year":"2019","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.radonc.2022.04.008_b0130","doi-asserted-by":"crossref","first-page":"407","DOI":"10.14338\/IJPT-16-00021.1","article-title":"Free breathing versus breath-hold scanning beam proton therapy and cardiac sparing in breast cancer","volume":"3","author":"Yu","year":"2016","journal-title":"Int J Part Ther"},{"key":"10.1016\/j.radonc.2022.04.008_b0135","doi-asserted-by":"crossref","first-page":"723","DOI":"10.1016\/j.ijrobp.2015.06.042","article-title":"Delineation of supraclavicular target volumes in breast cancer radiation therapy. In reply to Yang and Guo","volume":"93","author":"Brown","year":"2015","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.radonc.2022.04.008_b0140","doi-asserted-by":"crossref","first-page":"268","DOI":"10.1016\/j.ijrobp.2015.08.022","article-title":"Mapping patterns of ipsilateral supraclavicular nodal metastases in breast cancer: rethinking the clinical target volume for high-risk patients","volume":"93","author":"Jing","year":"2015","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.radonc.2022.04.008_b0145","doi-asserted-by":"crossref","first-page":"2967","DOI":"10.1118\/1.4921046","article-title":"A fast GPU-based Monte Carlo simulation of proton transport with detailed modeling of nonelastic interactions","volume":"42","author":"Wan Chan Tseung","year":"2015","journal-title":"Med Phys"},{"key":"10.1016\/j.radonc.2022.04.008_b0150","doi-asserted-by":"crossref","first-page":"1535","DOI":"10.1016\/j.ijrobp.2016.03.041","article-title":"Clinically applicable Monte Carlo-based biological dose optimization for the treatment of head and neck cancers with spot-scanning proton therapy","volume":"95","author":"Wan Chan Tseung","year":"2016","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.radonc.2022.04.008_b0155","doi-asserted-by":"crossref","first-page":"e71","DOI":"10.1016\/j.prro.2019.08.011","article-title":"Incorporation of biologic response variance modeling into the clinic: limiting risk of brachial plexopathy and other late effects of breast cancer proton beam therapy","volume":"10","author":"Mutter","year":"2020","journal-title":"Pract Radiat Oncol"},{"key":"10.1016\/j.radonc.2022.04.008_b0160","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1120\/jacmp.v15i6.4957","article-title":"Surface imaging-based analysis of intrafraction motion for breast radiotherapy patients","volume":"15","author":"Wiant","year":"2014","journal-title":"J Appl Clin Med Phys"},{"key":"10.1016\/j.radonc.2022.04.008_b0165","unstructured":"Common terminology criteria for adverse events version 5.0. 2017."},{"key":"10.1016\/j.radonc.2022.04.008_b0170","doi-asserted-by":"crossref","first-page":"1049","DOI":"10.1200\/JCO.2015.63.1010","article-title":"Long-Term Prognostic risk after neoadjuvant chemotherapy associated with residual cancer burden and breast cancer subtype","volume":"35","author":"Symmans","year":"2017","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.radonc.2022.04.008_b0175","doi-asserted-by":"crossref","first-page":"567","DOI":"10.1001\/archsurg.141.6.567","article-title":"A single-center experience with inflammatory breast cancer, 1985-2003","volume":"141","author":"Smoot","year":"2006","journal-title":"Arch Surg"},{"key":"10.1016\/j.radonc.2022.04.008_b0180","doi-asserted-by":"crossref","first-page":"376","DOI":"10.1097\/00000421-199210000-00002","article-title":"Inflammatory breast cancer: integration of irradiation, surgery, and chemotherapy","volume":"15","author":"Pisansky","year":"1992","journal-title":"Am J Clin Oncol"},{"key":"10.1016\/j.radonc.2022.04.008_b0185","doi-asserted-by":"crossref","first-page":"402","DOI":"10.1016\/j.prro.2019.05.011","article-title":"Excellent locoregional control in inflammatory breast cancer with a personalized radiation therapy approach","volume":"9","author":"Stecklein","year":"2019","journal-title":"Pract Radiat Oncol"},{"key":"10.1016\/j.radonc.2022.04.008_b0190","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1016\/j.ijrobp.2021.05.110","article-title":"Proton therapy for breast cancer: a consensus statement from the particle therapy cooperative Group Breast Cancer Subcommittee","volume":"111","author":"Mutter","year":"2021","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.radonc.2022.04.008_b0195","doi-asserted-by":"crossref","first-page":"346","DOI":"10.1016\/j.clon.2018.01.017","article-title":"A dosimetric comparison of breast radiotherapy techniques to treat locoregional lymph nodes including the internal mammary chain","volume":"30","author":"Ranger","year":"2018","journal-title":"Clin Oncol (R Coll Radiol)"},{"key":"10.1016\/j.radonc.2022.04.008_b0200","doi-asserted-by":"crossref","first-page":"1149","DOI":"10.1016\/j.ijrobp.2018.04.075","article-title":"A Randomized comparison of radiation therapy techniques in the management of node-positive breast cancer: primary outcomes analysis","volume":"101","author":"Jagsi","year":"2018","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.radonc.2022.04.008_b0205","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1016\/j.ijrobp.2020.03.012","article-title":"End-of-range radiobiological effect on rib fractures in patients receiving proton therapy for breast cancer","volume":"107","author":"Wang","year":"2020","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.radonc.2022.04.008_b0210","doi-asserted-by":"crossref","first-page":"709","DOI":"10.1016\/j.ijrobp.2015.12.013","article-title":"Contemporary toxicity profile of breast brachytherapy versus external beam radiation after lumpectomy for breast cancer","volume":"94","author":"Huo","year":"2016","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.radonc.2022.04.008_b0215","doi-asserted-by":"crossref","first-page":"240","DOI":"10.3390\/jpm12020240","article-title":"Effects of tumor-rib distance and dose-dependent rib volume on radiation-induced rib fractures in patients with breast cancer","volume":"12","author":"Lee","year":"2022","journal-title":"J Pers Med"},{"key":"10.1016\/j.radonc.2022.04.008_b0220","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1016\/j.radonc.2014.01.005","article-title":"Prophylactic use of Mepitel Film prevents radiation-induced moist desquamation in an intra-patient randomised controlled clinical trial of 78 breast cancer patients","volume":"110","author":"Herst","year":"2014","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.radonc.2022.04.008_b0225","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1016\/j.tipsro.2018.05.004","article-title":"Breast cancer patients report reduced sensitivity and pain using a barrier film during radiotherapy \u2013 A Danish intra-patient randomized multicentre study","volume":"7","author":"M\u00f8ller","year":"2018","journal-title":"Tech Innov Patient Support Radiat Oncol"},{"key":"10.1016\/j.radonc.2022.04.008_b0230","doi-asserted-by":"crossref","first-page":"91","DOI":"10.3857\/roj.2018.00451","article-title":"Radiotherapy for initial clinically positive internal mammary nodes in breast cancer","volume":"37","author":"Kim","year":"2019","journal-title":"Radiat Oncol J"},{"key":"10.1016\/j.radonc.2022.04.008_b0235","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1186\/s13014-020-1464-0","article-title":"Optimal radiotherapy for patients with internal mammary lymph node metastasis from breast cancer","volume":"15","author":"Yang","year":"2020","journal-title":"Radiat Oncol"}],"container-title":["Radiotherapy and Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S016781402200189X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S016781402200189X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,29]],"date-time":"2025-09-29T05:21:13Z","timestamp":1759123273000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S016781402200189X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,6]]},"references-count":47,"alternative-id":["S016781402200189X"],"URL":"https:\/\/doi.org\/10.1016\/j.radonc.2022.04.008","relation":{},"ISSN":["0167-8140"],"issn-type":[{"value":"0167-8140","type":"print"}],"subject":[],"published":{"date-parts":[[2022,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Proton therapy for the treatment of inflammatory breast cancer","name":"articletitle","label":"Article Title"},{"value":"Radiotherapy and Oncology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.radonc.2022.04.008","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 The Authors. Published by Elsevier B.V.","name":"copyright","label":"Copyright"}]}}